These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36226442)

  • 1. Association of Human Leukocyte Antigen Alleles and Hypersensitivity of Efavirenz/Nevirapine in HIV-Infected Chinese Patients.
    Zhou XY; Li CX; Zhang JB; Tan JT; -Yang X; Albarmaqi RA; Li YY; Kuang YQ
    AIDS Res Hum Retroviruses; 2022 Dec; 38(12):884-889. PubMed ID: 36226442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-dependent hypersensitivity reaction to nevirapine in Chinese Han HIV-infected patients.
    Gao S; Gui XE; Liang K; Liu Z; Hu J; Dong B
    AIDS Res Hum Retroviruses; 2012 Jun; 28(6):540-3. PubMed ID: 21902584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DRB1*01 associated with cutaneous hypersensitivity induced by nevirapine and efavirenz.
    Vitezica ZG; Milpied B; Lonjou C; Borot N; Ledger TN; Lefebvre A; Hovnanian A
    AIDS; 2008 Feb; 22(4):540-1. PubMed ID: 18301070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel association of efavirenz induced severe cutaneous adverse reactions with HLA- DRB1*03:01: A case-control study from North-East India.
    Singh M; Pawar M; Bhargava S; Gupta P; Adhicari P
    Dermatol Ther; 2021 Mar; 34(2):e14760. PubMed ID: 33421254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of human leukocyte antigen alleles and nevirapine hypersensitivity in a Malawian HIV-infected population.
    Carr DF; Chaponda M; Jorgensen AL; Castro EC; van Oosterhout JJ; Khoo SH; Lalloo DG; Heyderman RS; Alfirevic A; Pirmohamed M
    Clin Infect Dis; 2013 May; 56(9):1330-9. PubMed ID: 23362284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients.
    Chantarangsu S; Mushiroda T; Mahasirimongkol S; Kiertiburanakul S; Sungkanuparph S; Manosuthi W; Tantisiriwat W; Charoenyingwattana A; Sura T; Chantratita W; Nakamura Y
    Pharmacogenet Genomics; 2009 Feb; 19(2):139-46. PubMed ID: 19104471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles.
    Pavlos R; McKinnon EJ; Ostrov DA; Peters B; Buus S; Koelle D; Chopra A; Schutte R; Rive C; Redwood A; Restrepo S; Bracey A; Kaever T; Myers P; Speers E; Malaker SA; Shabanowitz J; Jing Y; Gaudieri S; Hunt DF; Carrington M; Haas DW; Mallal S; Phillips EJ
    Sci Rep; 2017 Aug; 7(1):8653. PubMed ID: 28819312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between human leukocyte antigen polymorphisms and hypersensitivity to antiretroviral therapy in patients with human immunodeficiency virus: a meta-analysis.
    Hu K; Xiang Q; Wang Z; Mu GY; Zhang Z; Ma LY; Xie QF; Chen SQ; Zhou S; Zhang XD; Cui YM
    BMC Infect Dis; 2019 Jul; 19(1):583. PubMed ID: 31277607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetic information derived from analysis of HLA alleles.
    Gatanaga H; Honda H; Oka S
    Pharmacogenomics; 2008 Feb; 9(2):207-14. PubMed ID: 18370849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-allelotype associations with nevirapine-induced hypersensitivity reactions and hepatotoxicity: a systematic review of the literature and meta-analysis.
    Cornejo Castro EM; Carr DF; Jorgensen AL; Alfirevic A; Pirmohamed M
    Pharmacogenet Genomics; 2015 Apr; 25(4):186-98. PubMed ID: 25714001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing-based HLA typing reveals the association of HLA-B*46:01:01 and HLA-DRB1*09:01:02 alleles with carbamazepine-induced hypersensitivity reactions in Vietnamese patients with epilepsy.
    Bui TP; Nguyen LTT; Le PL; Le NTT; Nguyen TD; Van Nguyen L; Van Nguyen AT; Trinh TH
    Hum Immunol; 2023 Mar; 84(3):186-195. PubMed ID: 36725456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population.
    Carr DF; Bourgeois S; Chaponda M; Takeshita LY; Morris AP; Castro EM; Alfirevic A; Jones AR; Rigden DJ; Haldenby S; Khoo S; Lalloo DG; Heyderman RS; Dandara C; Kampira E; van Oosterhout JJ; Ssali F; Munderi P; Novelli G; Borgiani P; Nelson MR; Holden A; Deloukas P; Pirmohamed M
    J Antimicrob Chemother; 2017 Apr; 72(4):1152-1162. PubMed ID: 28062682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals.
    Mbuagbaw L; Mursleen S; Irlam JH; Spaulding AB; Rutherford GW; Siegfried N
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD004246. PubMed ID: 27943261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysis.
    Shubber Z; Calmy A; Andrieux-Meyer I; Vitoria M; Renaud-Théry F; Shaffer N; Hargreaves S; Mills EJ; Ford N
    AIDS; 2013 Jun; 27(9):1403-12. PubMed ID: 23343913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity.
    Keane NM; Pavlos RK; McKinnon E; Lucas A; Rive C; Blyth CC; Dunn D; Lucas M; Mallal S; Phillips E
    AIDS; 2014 Aug; 28(13):1891-901. PubMed ID: 24911354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nevirapine patch testing in Thai human immunodeficiency virus infected patients with nevirapine drug hypersensitivity.
    Prasertvit P; Chareonyingwattana A; Wattanakrai P
    Contact Dermatitis; 2017 Dec; 77(6):379-384. PubMed ID: 28782122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between ABCB1, CYP2A6, CYP2B6, CYP2D6, and CYP3A5 alleles in relation to efavirenz and nevirapine pharmacokinetics in HIV-infected individuals.
    Heil SG; van der Ende ME; Schenk PW; van der Heiden I; Lindemans J; Burger D; van Schaik RH
    Ther Drug Monit; 2012 Apr; 34(2):153-9. PubMed ID: 22354160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin.
    Manosuthi W; Mankatitham W; Lueangniyomkul A; Chimsuntorn S; Sungkanuparph S
    HIV Med; 2008 May; 9(5):294-9. PubMed ID: 18400076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting factors for unsuccessful switching from nevirapine to efavirenz in HIV-infected patients who developed nevirapine-associated skin rash.
    Kiertiburanakul S; Malathum K; Watcharananan S; Sathapatayavongs B; Sungkanuparph S
    Int J STD AIDS; 2009 Mar; 20(3):176-9. PubMed ID: 19255265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative durability of nevirapine versus efavirenz in first-line regimens during the first year of initiating antiretroviral therapy among Swaziland HIV-infected adults.
    Takuva S; Evans D; Zuma K; Okello V; Louwagie G
    Pan Afr Med J; 2013; 15():5. PubMed ID: 23847702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.